Literature DB >> 11012915

Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events.

Y Wang1, Y P Wang, Y C Tay, D C Harris.   

Abstract

BACKGROUND: As an experimental analogue of human focal glomerular sclerosis (FGS), adriamycin (ADR)-induced nephropathy is well-characterized in rats. Previously, this model has not been fully established in mice. The extension of this model to the mouse would be useful in the application of genetic and monoclonal antibody technology to characterize mechanisms of progressive renal disease. Herein, we describe a stable and reproducible murine model of chronic proteinuria induced by ADR.
METHODS: Male BALB/c mice were intravenously injected with a single dose of ADR (10 to 11 mg/kg). Seven mice were sacrificed at weeks 1, 2, 4, and 6. Renal function, quantitative morphometric analysis, and electron microscopic studies were performed. Peripheral CD4+ and CD8+ T cells were evaluated using flow cytometric analysis of splenocytes. The leukocytic inflammatory pattern was analyzed by immunohistochemical examination.
RESULTS: Overt proteinuria was observed from day 5 and remained significantly elevated throughout the study period. A focal increase in reabsorption droplets in tubular cells appeared at weeks 1 and 2, and numerous intraluminal casts were present after two weeks. Glomerular vacuolation and mild FGS appeared at week 4. At week 6, extensive focal and even global glomerular sclerosis, associated with moderate interstitial expansion and severe inflammation, were observed. A prominent macrophage infiltration appeared within both interstitium and glomeruli at week 2, followed by accumulation of both CD4+ and CD8+ T cells in interstitium but not glomeruli. There were almost no B lymphocytes seen at any time.
CONCLUSION: This model should be useful in unraveling the pathogenesis of glomerular and interstitial inflammation and fibrosis in chronic proteinuric renal disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11012915     DOI: 10.1046/j.1523-1755.2000.00342.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  117 in total

1.  Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria.

Authors:  Chunsun Dai; Moin A Saleem; Lawrence B Holzman; Peter Mathieson; Youhua Liu
Journal:  Kidney Int       Date:  2010-03-10       Impact factor: 10.612

2.  Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria.

Authors:  Young Sun Kang; Yingjian Li; Chunsun Dai; Lawrence P Kiss; Chuanyue Wu; Youhua Liu
Journal:  Kidney Int       Date:  2010-05-26       Impact factor: 10.612

3.  The β isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy.

Authors:  Changbin Li; Yan Ge; Lance Dworkin; Ai Peng; Rujun Gong
Journal:  J Pathol       Date:  2016-03-16       Impact factor: 7.996

4.  The Alzheimer's disease risk factor CD2AP maintains blood-brain barrier integrity.

Authors:  J Nicholas Cochran; Travis Rush; Susan C Buckingham; Erik D Roberson
Journal:  Hum Mol Genet       Date:  2015-09-10       Impact factor: 6.150

5.  Adriamycin alters glomerular endothelium to induce proteinuria.

Authors:  Marie Jeansson; Karin Björck; Olav Tenstad; Börje Haraldsson
Journal:  J Am Soc Nephrol       Date:  2008-12-10       Impact factor: 10.121

6.  Regulatory T cells in renal disease.

Authors:  Yuan Min Wang; Min Hu; Ya Wang; Tania Polhill; Geoff Yu Zhang; Yiping Wang; Vincent W S Lee; David C H Harris; Stephen I Alexander
Journal:  Int J Clin Exp Med       Date:  2008-08-20

7.  KLF4-dependent epigenetic remodeling modulates podocyte phenotypes and attenuates proteinuria.

Authors:  Kaori Hayashi; Hiroyuki Sasamura; Mari Nakamura; Tatsuhiko Azegami; Hideyo Oguchi; Yusuke Sakamaki; Hiroshi Itoh
Journal:  J Clin Invest       Date:  2014-05-08       Impact factor: 14.808

8.  Catalpol alleviates adriamycin-induced nephropathy by activating the SIRT1 signalling pathway in vivo and in vitro.

Authors:  Jiangnan Zhang; Ran Bi; Qiang Meng; Changyuan Wang; Xiaokui Huo; Zhihao Liu; Chong Wang; Pengyuan Sun; Huijun Sun; Xiaodong Ma; Jingjing Wu; Kexin Liu
Journal:  Br J Pharmacol       Date:  2019-12-11       Impact factor: 8.739

9.  Inhibition of p38 mitogen-activated protein kinase and transforming growth factor-beta1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy.

Authors:  Jinhua Li; Naomi Vittoria Campanale; Rong Jiao Liang; James Antony Deane; John Frederick Bertram; Sharon Denise Ricardo
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

10.  Wnt/beta-catenin signaling promotes renal interstitial fibrosis.

Authors:  Weichun He; Chunsun Dai; Yingjian Li; Gang Zeng; Satdarshan P Monga; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2009-03-18       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.